Salute e Benessere

Bulat Utemuratov Foundation signs MOU with world-leading autism expert Connie…

Recognition of the importance of early diagnosis and intervention for ASD is growing, demonstrating clear benefits of the effectiveness of treatment and improving quality of life for children and their families. The Foundation will work with Dr. Kasari to provide training for the Foundation's specialists and Trainer of Trainers ("TOT"), to train the next generation of experts. Recognition of the importance of early diagnosis and intervention for ASD is growing, demonstrating clear…
PR Newswire
27/09/2023

T-knife Therapeutics Announces Four Presentations at the Upcoming Society for…

SAN FRANCISCO and BERLIN, Sept.27, 2023(GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing T cell receptor-based immunotherapies that deliver transformational benefits to cancer patients, today announced four poster presentations at the Society for Immunotherapy of Cancer (SITC) Annual Meeting which will take place November 1-5, 2023 in San Diego, CA. “We are excited to share the breadth of our platform technologies in four...
Nasdaq GlobeNewswire
27/09/2023

DentalMonitoring Announces Integration with Cloud Based Practice Management…

UK-based Retainers4life is partnering with DentalMonitoring to provide a unique RetentionMonitoring system for private practice and NHS orthodontists. Retainers4life will use the DentalMonitoring software and ScanBoxpro to monitor patient retention to help patients keep their perfect smile, long after treatment completion. UK-based Retainers4life is partnering with DentalMonitoring to provide a unique RetentionMonitoring system for private practice and NHS orthodontists. Retainers4life will…
PR Newswire
27/09/2023

Emmes Introduces Telehealth Capabilities into Advantage eClinical

The addition of telehealth capabilities is part of a much wider development plan for Emmes' third generation clinical data platform. The company's vision is to create the first unified, flexible, digital trial infrastructure that minimizes disruption for sites and participants and is more accessible. Our single, flexible platform accommodates all trial modalities – traditional, decentralized including hybrid and fully virtual – as well as the needs of patients, sponsors and sites. It also…
PR Newswire
27/09/2023

Gerresheimer at CPHI: focus on high-value solutions and sustainability

- EcoDesign and environmentally friendly packaging options ensure greater sustainability - EcoDesign and environmentally friendly packaging options ensure greater sustainability DUSSELDORF, Germany,Sept. 27, 2023/PRNewswire/ -- Gerresheimer, an innovative system and solution provider and a global partner for the pharma and biotech industry, will present its extensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at...
PR Newswire
27/09/2023

AIVF Expands Launching the First AI-Powered IVF Solution at the Perfetto Clinic…

AIVF's expansion significantly addresses the growing demand for assisted reproductive technologies in Brazil. From 2013-2019, the number of registered clinics in Brazil increased by 63%, and the number of frozen embryos increased threefold. [1] AIVF's expansion significantly addresses the growing demand for assisted reproductive technologies inBrazil. From 2013-2019, the number of registered clinics inBrazilincreased by 63%, and the number of frozen embryos increased threefold...
PR Newswire
27/09/2023

IBA finalizes contract with Medtechnica Ltd for two Proteus®ONE proton therapy…

Louvain-La-Neuve, Belgium, September 27, 2023 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed the final contract with Medtechnica Ltd for the installation of two Proteus ® ONE 1 compact proton therapy solutions at the Sourasky Medical Center (Ichilov Hospital) in Tel Aviv, Israel. This follows the signature of a...
Nasdaq GlobeNewswire
27/09/2023

Akari Therapeutics to Present at Emerging Growth Conference

BOSTON and LONDON, Sept.27, 2023(GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced that the company will participate in the Emerging Growth Conference being held October 4 and 5, 2023. President and CEO Rachelle Jacques will present an overview of the company and its lead asset nomacopan, a bispecific inhibitor of complement C5 and leukotriene B4 (LTB4), on...
Nasdaq GlobeNewswire
27/09/2023

Zeus Launches Next-Generation Tubing for Bioresorbable Vascular Scaffolds

"Our new Absorv XSE oriented tubing gives medical device manufacturers another tool in their design toolkit," noted Carl Liebert, Director of Product Management at Zeus. "As our customers set out to develop next-generation devices, this latest Zeus tubing platform helps them expand the types of applications they address and produce better overall designs." "Our new Absorv XSE oriented tubing gives medical device manufacturers another tool in their design toolkit,"…
PR Newswire
27/09/2023

Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1…

thCongress of the French Society of Endocrinology, being held October 4-7, 2023, in Marseille, France. Jean-Philippe Bertocchio, M.D., Ph.D., Clinical Nephrologist at Pitié-Salpêtrière Hospital, Paris, and Michel Ovize, M.D., Ph.D., Senior Medical Director of Amolyt, will discuss the effects of eneboparatide on the kidneys of patients with hypoparathyroidism. The presentation will also include data on eneboparatide's effect on the bone and the results of the company's Phase 2a clinical...
Nasdaq GlobeNewswire
27/09/2023

Dynamic Digital Radiography Market to Reach $636.5 Million, by 2032 at 11.0%…

Request Sample of the Report on Dynamic Digital Radiography Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/194915 Request Sample of the Report on Dynamic Digital Radiography Market Forecast 2032-https://www.alliedmarketresearch.com/request-sample/194915 Dynamic Digital Radiography (DDR) is a new low dose X-ray imaging technology that enables visualization of anatomical anatomy in motion. It is capable of obtaining up to 15 consecutive radiographs in a...
PR Newswire
27/09/2023

Cosmo and Glenmark announce the signing of Distribution and License Agreements…

Alessandro Della Chà, CEO of Cosmo, said, "We are very pleased to partner with Glenmark. Their strong expertise in the commercialization of pharmaceutical compounds gives us great confidence in their ability to successfully market Winlevi®. We look forward to eventually making Winlevi® available to more patients around the globe." Alessandro Della Chà, CEO of Cosmo, said, "We are very pleased to partner with Glenmark. Their strong expertise in the commercialization of…
PR Newswire
27/09/2023

Major shareholder announcements from Burlington Loan Management DAC and Davidson…

September 27, 2023 – Company announcement no. 8 Please see attachment.Contact informationInvestor Relations Anders Mohr Christensen +45 2515 2364dkamc@chr-hansen.com Press Relations Sanne Seyer-Hansen +45 6038 6207dksash@chr-hansen.comAbout Chr. Hansen Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen, we are strongly positioned to...
Nasdaq GlobeNewswire
27/09/2023

Seven AI/ML for Life Sciences Companies Identified as Innovators in New…

LONDON, Sept. 27, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its annual Companies to Watch report. This year's report identifies seven innovators trying to change the drug discovery and development paradigm by utilizing innovative artificial intelligence (AI) and machine learning (ML) technologies. Drawing on data and analytics from BioWorld, published by Clarivate…
PR Newswire
27/09/2023

XNK Therapeutics presented two posters at the NK2023 conference in Oslo

The poster on BC shows the feasibility of expanding autologous NK cells from peripheral blood mononuclear cells (PBMCs) from BC patients. Cells were collected from patients both before and after chemotherapy treatment and the expansion and activation process was successful at both collection points demonstrating flexibility in timing for manufacturing. There were no significant differences in total cell yield, NK fraction or NK cell cytotoxicity against tumor cells between cultures started with…
PR Newswire
27/09/2023

Deux premiers patients atteints de leucémie ont reçu la thérapie SMART101 de…

Aucune toxicité observéechez les deux premiers patients traités SMART101 est conçu pour accélérer la reconstitution immunitaire après une greffe de cellules souches haplo-identiquesuivie d'un traitement par cyclophosphamide , afin de lutter contre les rechutes et les infections.PARIS, France , 27 septembre–2023- Smart Immune, société de biotechnologie au stade clinique qui développe la plateforme de thérapie cellulaire...
Nasdaq GlobeNewswire
27/09/2023

ONWARD® Announces First-in-Human Implant of ARC-IM™ Stimulator with…

Pioneering procedure pairs Company's investigational ARC-IM implantable spinal cord stimulator with an investigational brain-computer interface ONWARD ARC-IM delivers targeted, programmed ARC-IM Therapy to the spinal cord to restore movement and other functions after spinal cord injury. ARC-IM Therapy has been applied across multiple clinical feasibility studies to restore mobility and stabilize blood pressure after SCI. For the first time, ARC-IM Therapy has now also been used to restore...
Nasdaq GlobeNewswire
27/09/2023

ObsEva Files half Year 2023 Financial Statements

ObsEva Fileshalf Year2023Financial Statements Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – September 27 , 2023 –ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, today published its Half Year 2023 Financial Statements. The Half Year 2023 Financial Statements may be found on the financial section of the Company's website,her...
Nasdaq GlobeNewswire
27/09/2023

Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen…

Independent global leaders in medical research on women's health, Professor Amanda Black and Professor Wulf Utian, to deliver two presentations each on E4E4 is a key active pharmaceutical ingredient in Estelle® and Donesta® productsDifferentiated efficacy and safety in contraception and postmenopausal symptoms from positive Phase 3 trialsLiege, Belgium ,27 September2023– 7:00 CEST– Mithra (Euronext Brussels: MITRA), a company dedicated to...
Nasdaq GlobeNewswire
27/09/2023

BioSenic performs further analysis of its phase 2 clinical trial data, leading…

BioSenic performs further analysis of its phase 2 clinical trial data, leading to an optimal administration scheme for its next late-stage trial of arsenic trioxide in cGvHDNew post-hoc analysis suggests a repeated administration cycle for BioSenic's upcoming phase 3 trial of oral arsenic trioxide (ATO) in chronic graft-versus-host disease (cGvHD)Mont-Saint-Guibert, Belgium, September 27 , 2023 , 7 .00am CEST...
Nasdaq GlobeNewswire
27/09/2023

HRH Princess Astrid of Belgium visits Telix's New European Manufacturing…

The royal visit comes ahead of the Belgian Economic Mission to Australia, which will take place in Melbourne and Sydney from 19 to 28 October 2023. The mission – led by HRH, Princess Astrid of Belgium, Representative of His Majesty the King of Belgium – features events that highlight successful collaboration between Belgium and Australia. Telix is co-hosting a seminar with The Peter MacCallum Cancer Centre in Melbourne on the subject of innovation in nuclear medicine. The royal visit comes...
PR Newswire
27/09/2023

Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a…

Key Takeaways from the Atherosclerotic Cardiovascular Disease Market Report Key Takeaways from the Atherosclerotic Cardiovascular Disease Market Report Discover which therapies are expected to grab the major atherosclerotic cardiovascular disease market share @Atherosclerotic Cardiovascular Disease Market Report Atherosclerotic Cardiovascular Disease Overview Atherosclerotic cardiovascular disease (ASCVD) is a medical condition that causes arteries to constrict, limiting...
PR Newswire
26/09/2023

Mdxhealth Signs Research Collaboration with University of Oxford to Assess the…

NEWS RELEASESeptember26 , 2023 , 5:00PM EDT / 23:00 CET Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatmentfor Localized Prostate CancerIRVINE, CA, and HERSTAL, BELGIUM – September 26 , 2023 –MDxHealth SA (NASDAQ/Euronext: MDXH), a leading commercial-stage precision diagnostics company, today announced a research collaboration...
Nasdaq GlobeNewswire
26/09/2023

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM

Rapport Financier Semestriel 30 Juin 2023 PHAXIAM Attachment PHXM_Master RFA 2023_06 (1)
Nasdaq GlobeNewswire
26/09/2023
Altri  Comunicati